Jonathan E. Lim - 20 Jul 2021 Form 4 Insider Report for Erasca, Inc. (ERAS)

Signature
/s/ Ebun S. Garner, Attorney-in-Fact
Issuer symbol
ERAS
Transactions as of
20 Jul 2021
Net transactions value
$0
Form type
4
Filing time
20 Jul 2021, 20:58:45 UTC
Previous filing
15 Jul 2021
Next filing
03 Feb 2022

Key filing fact

Jonathan E. Lim filed Form 4 for Erasca, Inc. (ERAS) on 20 Jul 2021.

Key facts

  • This page summarizes Jonathan E. Lim's Form 4 filing for Erasca, Inc. (ERAS).
  • 6 reported transactions and 4 derivative rows are listed below.
  • Filing timestamp: 20 Jul 2021, 20:58.

Change

  • Previous filing in this sequence was filed on 15 Jul 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

ERAS transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+5,135,390
Change %
+34%
Price
Shares after
20,156,222
Date
20 Jul 2021
Ownership
By Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005
Footnotes
F1, F2
ERAS transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+5,441,027
Change %
+84%
Price
Shares after
11,899,360
Date
20 Jul 2021
Ownership
By City Hill, LLC
Footnotes
F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

ERAS transaction Derivative

Series A Preferred Stock

Conversion of derivative security

Transaction value
Shares
-6,162,468
Change %
-100%
Price
Shares after
0
Date
20 Jul 2021
Ownership
By the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005
Underlying class
Common Stock
Underlying amount
5,135,390
Exercise price
$0.000000
Footnotes
F1, F2
ERAS transaction Derivative

Series A Preferred Stock

Conversion of derivative security

Transaction value
Shares
-6,081,233
Change %
-100%
Price
Shares after
0
Date
20 Jul 2021
Ownership
By City Hill, LLC
Underlying class
Common Stock
Underlying amount
5,067,694
Exercise price
$0.000000
Footnotes
F1, F3
ERAS transaction Derivative

Series B-1 Preferred Stock

Conversion of derivative security

Transaction value
Shares
-336,000
Change %
-100%
Price
Shares after
0
Date
20 Jul 2021
Ownership
By City Hill, LLC
Underlying class
Common Stock
Underlying amount
280,000
Exercise price
$0.000000
Footnotes
F1, F3
ERAS transaction Derivative

Series B-2 Preferred Stock

Conversion of derivative security

Transaction value
Shares
-112,000
Change %
-100%
Price
Shares after
0
Date
20 Jul 2021
Ownership
By City Hill, LLC
Underlying class
Common Stock
Underlying amount
93,333
Exercise price
$0.000000
Footnotes
F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of the Issuer's Series A and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 1.2-for-1 share, immediately prior to the consummation of the Issuer's initial public offering.
F2 The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.
F3 Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.

Remarks:

Chairman and Chief Executive Officer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .